… , for the first time, that cardiac resynchronisation therapy with biventricular pacing may reduce
all-cause mortality in a selected group of patients with chronic heart failure. This may now …

… Cardiac resynchronization therapy (CRT) has become an accepted adjunct therapy for
patients with drug-refractory HF and ventricular conduction delay. Cardiac resynchronization …

… of the InSync/InSync ICD Italian Registry, a prospective observational study that includes
patients with HF, LV dysfunction, and wide QRS complexes who received a device capable of …

Background: Studies reporting the long‐term survival of patients treated with cardiac
resynchronization therapy (CRT) outside the realm of randomized controlled trials are still lacking. …

… of the InSync ICD for the primary and secondary prevention of sudden death. The InSync
ICD was implanted in 142 patients (128 men; mean age65 ± 10years) with heart failure (mean …

Objectives: To determine the potential influence of cardiac resynchronization therapy (CRT)
on the frequency and types of ventricular arrhythmia (VA) in patients with an indication for …

… Cardiac resynchronization therapy (CRT) has been shown to improve HF symptoms and
decrease mortality. However, little data are available which specifically address the effects of …

… From 1999 to 2005, the InSync ICD Italian Registry prospectively … resynchronization therapy.
The registry included patients with mild to severe symptomatic chronic HF (New York Heart …

Chronic heart failure is one of the most important geriatric syndromes, associated with disability,
increased hospital admissions, and high mortality. The aim of this study was to evaluate …

… or nonischemic cardiomyopathy has been shown in several large-scale randomized trials.
Similarly, cardiac resynchronization therapy (CRT) alone or associated with ICD has been …